Table of Contents

company-logo

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial. The company also develops coronavirus vaccine candidates, such as VBI-2902 and VBI-2901. In addition, it engages in the development of vaccine platforms and products for licensing to pharmaceutical companies and biotechnology companies. It has collaboration and license agreements with Brii Biosciences Limited; and GlaxoSmithKline Biologicals S.A. The company also has a collaboration with the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. VBI Vaccines Inc. has collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is headquartered in Cambridge, Massachusetts.

VBI Vaccines Dividend Announcement

• VBI Vaccines announced a annually dividend of $0.00 per ordinary share which will be made payable on . Ex dividend date: 2012-04-02
• VBI Vaccines's trailing twelve-month (TTM) dividend yield is -%

VBI Vaccines Dividend History

Ex-Div dateDividend amountDividend typePay date
2012-04-02$0.00annually
2006-01-12$0.00annually
2003-12-18$0.00annually

VBI Vaccines Dividend per year

VBI Vaccines Dividend Yield

VBI Vaccines current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing VBI Vaccines stock? Use our calculator to estimate your expected dividend yield:

VBI Vaccines Financial Ratios

P/E ratio-0.02
PEG ratio0.00
P/B ratio-0.29
ROE-1081.80%
Payout ratio0.00%
Current ratio0.34
Quick ratio0.21
Cash Ratio0.16

VBI Vaccines Dividend FAQ

Does VBI Vaccines stock pay dividends?
VBI Vaccines does not currently pay dividends to its shareholders.
Has VBI Vaccines ever paid a dividend?
No, VBI Vaccines has no a history of paying dividends to its shareholders. VBI Vaccines is not known for its dividend payments.
Why doesn't VBI Vaccines pay dividends?
There are several potential reasons why VBI Vaccines would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will VBI Vaccines ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While VBI Vaccines has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is VBI Vaccines a dividend aristocrat?
VBI Vaccines is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is VBI Vaccines a dividend king?
VBI Vaccines is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is VBI Vaccines a dividend stock?
No, VBI Vaccines is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy VBI Vaccines stocks?
To buy VBI Vaccines you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy VBI Vaccines stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.